Table of Contents
Chapter 1. Global Antiviral Therapeutics Market Executive Summary
1.1. Global Antiviral Therapeutics Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug
1.3.2. By Therapy
1.3.3. By Distribution
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Antiviral Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antiviral Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Viral Diseases
3.1.2. Increasing Pharmaceutical Research & Development
3.1.3. Growing Healthcare Expenditure
3.2. Market Challenges
3.2.1. Side Effects of Antiviral Drugs
3.2.2. High Cost of Drug Development
3.3. Market Opportunities
3.3.1. Advancements in Drug Development Technologies
3.3.2. Growing Demand for Personalized Medicine
3.3.3. Expansion in Emerging Markets
Chapter 4. Global Antiviral Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antiviral Therapeutics Market Size & Forecasts by Drug 2022-2032
5.1. Segment Dashboard
5.2. Global Antiviral Therapeutics Market: Drug Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Hepatitis Antiviral Drug
5.2.2. Herpes Antiviral Drug
5.2.3. HIV Antiviral Drug
5.2.4. Influenza Antiviral Drug
Chapter 6. Global Antiviral Therapeutics Market Size & Forecasts by Therapy 2022-2032
6.1. Segment Dashboard
6.2. Global Antiviral Therapeutics Market: Therapy Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. DNA Polymerase Inhibitors
6.2.2. Non-nucleosides
6.2.3. Purine Nucleoside Analogues
6.2.4. Pyrimidine Nucleoside Analogues
6.2.5. Neuraminidase Inhibitors
6.2.6. Protease Inhibitors
6.2.7. Reverse Transcriptase Inhibitors
Chapter 7. Global Antiviral Therapeutics Market Size & Forecasts by Distribution 2022-2032
7.1. Segment Dashboard
7.2. Global Antiviral Therapeutics Market: Distribution Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacy
7.2.2. Independent Pharmacy & Drug Store
7.2.3. Online Pharmacy
Chapter 8. Global Antiviral Therapeutics Market Size & Forecasts by Region 2022-2032
8.1. North America Antiviral Therapeutics Market
8.1.1. U.S. Antiviral Therapeutics Market
8.1.1.1. Drug breakdown size & forecasts, 2022-2032
8.1.1.2. Therapy breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution breakdown size & forecasts, 2022-2032
8.1.2. Canada Antiviral Therapeutics Market
8.2. Europe Antiviral Therapeutics Market
8.2.1. UK Antiviral Therapeutics Market
8.2.2. Germany Antiviral Therapeutics Market
8.2.3. France Antiviral Therapeutics Market
8.2.4. Spain Antiviral Therapeutics Market
8.2.5. Italy Antiviral Therapeutics Market
8.2.6. Rest of Europe Antiviral Therapeutics Market
8.3. Asia-Pacific Antiviral Therapeutics Market
8.3.1. China Antiviral Therapeutics Market
8.3.2. India Antiviral Therapeutics Market
8.3.3. Japan Antiviral Therapeutics Market
8.3.4. Australia Antiviral Therapeutics Market
8.3.5. South Korea Antiviral Therapeutics Market
8.3.6. Rest of Asia Pacific Antiviral Therapeutics Market
8.4. Latin America Antiviral Therapeutics Market
8.4.1. Brazil Antiviral Therapeutics Market
8.4.2. Mexico Antiviral Therapeutics Market
8.4.3. Rest of Latin America Antiviral Therapeutics Market
8.5. Middle East & Africa Antiviral Therapeutics Market
8.5.1. Saudi Arabia Antiviral Therapeutics Market
8.5.2. South Africa Antiviral Therapeutics Market
8.5.3. Rest of Middle East & Africa Antiviral Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. AbbVie Inc.
9.3.3. Alkem Laboratories Limited
9.3.4. AstraZeneca PLC
9.3.5. Atea Pharmaceuticals, Inc.
9.3.6. Aurobindo Pharma Limited
9.3.7. Bristol-Myers Squibb Company
9.3.8. Cipla Ltd.
9.3.9. Cocrystal Pharma, Inc.
9.3.10. Daiichi Sankyo Company, Ltd.
9.3.11. Dr. Reddy's Laboratories Ltd.
9.3.12. Eli Lilly and Company
9.3.13. F. Hoffmann-La Roche Ltd
9.3.14. Gilead Sciences, Inc.
9.3.15. GlaxoSmithKline PLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes